-

Theramex Reinforces its Commitment to Women on International Women’s Day

  • We have partnered with amazing organisations to celebrate this special day
  • Our campaigns allow us to work harder than ever to improve women's lives
  • Internal communication and campaigns are a vital part in the support of women

LONDON--(BUSINESS WIRE)--International Women’s Day is an important date on the calendar to recognise and celebrate the social, economic, culture, political, scientific and many more achievements of women globally. At Theramex, every day is considered International Women’s Day because our sole focus is on the health needs of women. Although we celebrate the day, this is no time to stop or pause as there are many challenges to overcome for a fairer and equitable world. We celebrate this day by coming to work to add value to our patients propelled by our passion to improve women’s health and improve her quality of life.

“IWD reminds us that our work is crucial in the care and improvement of women’s health, as they navigate through different stages of life. Over the year we have collaborated with some amazing organisations to raise money for women in need, increase awareness on issues such as domestic violence and support organisations focused on education like Binti International, a charity who raise awareness and educate around period poverty. Our volunteer efforts compliment the work we are doing inside Theramex to make a difference in the lives of women and we are just getting started” said Robert Stewart, Theramex CEO.

This IWD, we will work even harder, dedicating our time to supporting and uplifting women. We provided the opportunity for our entire team to carve out time from their busy schedule to participate in fundraising activities and/or volunteering at a partnered charity.

“IWD 2022 theme, #BreakTheBias, is especially relevant to us, because we ardently believe that breaking the bias can only be achieved with true commitment from each and every one of us. We are committed to breaking the bias around the menopause in the workplace, we are committed to break the bias surrounding the psychological impact of domestic abuse through our CSR work” said Anjuna Kalsi, Theramex, Chief Human Resources Officer.

“As a new addition to the team, I am so excited to be part of Theramex. Being here every day to make a difference for a more inclusive and healthy world for women is a true inspiration” said Camilla Harder Hartvig, Theramex Chief Commercial Officer.

With this being Theramex’s 5th International Women’s Day we have partnered with some amazing organisations including Where Women Work to showcase the women within Theramex and the achievements they have gained throughout their careers. Our choice charity for our global Headquarters is Woman’s Trust, a mental health charity who provide free counselling and therapy for women who have experienced domestic abuse; we will be supporting other domestic abuse charities across the globe in communities where we work.

We look forward to the celebration but also for the opportunity to make a difference.

About Theramex

Theramex is a leading global speciality pharmaceutical company dedicated to women and their health. We support women at every stage of their lives by providing a broad portfolio of innovative and established brands covering contraception, fertility, menopause and osteoporosis. Our commitment is to listen to and understand our patients, serve their needs and offer healthcare solutions to help improve their lives. Our vision is to be a lifetime partner for women and the healthcare professionals who treat them by providing patient-focused and effective solutions that care for and support women through every stage of life.

Contacts

Jesús López | Associate Director, Communication & Digital | Jesus.Lopez@Theramex.com

More News From Theramex

Theramex Announces Agreement to Acquire the European Rights to Duphaston® and Femoston® From Viatris, Inc.

LONDON--(BUSINESS WIRE)--Theramex, a leading global speciality pharmaceutical company dedicated to women’s health, is pleased to announce that it has entered into an agreement to acquire the European rights to Duphaston® and Femoston® from Viatris Inc. Viatris retains the rights for Australia and Japan. The transaction is subject to customary regulatory and anti-trust approvals. “As we continue to strengthen our commitment to women’s health and improve our patients access to high quality treatm...

Theramex Enters Into an Exclusive Licensing Agreement With Radius Health Inc, to Commercialise ELADYNOS® ▼in the European Economic Area, the United Kingdom, Australia and Brazil

LONDON--(BUSINESS WIRE)--Theramex, a leading global speciality pharmaceutical company dedicated to women’s health, has entered into an exclusive licensing agreement with Radius Health, Inc., for the rights to commercialise ELADYNOS® (abaloparatide), a novel bone forming agent indicated for the treatment of osteoporosis in postmenopausal women at increased risk of fractures. Theramex will commercialise and distribute ELADYNOS® on an exclusive basis in the European Economic Area, the United Kingd...

Theramex Announces European Commission Marketing Authorization for Yselty® (linzagolix), an Oral GnRH Antagonist, for the Treatment of Symptoms of Uterine Fibroids

LONDON--(BUSINESS WIRE)--The European Commission (EC) has granted Marketing Authorization for Yselty® (linzagolix), an oral GnRH antagonist, indicated for the treatment of moderate to severe symptoms of Uterine Fibroids (UF) in adult women (over 18 years of age) of reproductive age. This announcement is in partnership with ObsEva SA (Nasdaq: OBSV), a biopharmaceutical company developing and commercializing novel therapies for women’s health. The EC decision follows the Committee for Medicinal P...
Back to Newsroom